Regulated cell death and adaptive stress responses

Cellular and Molecular Life Sciences

Volumn 73, Issue 11-12, 2016, Pages 2405-2410

  Galluzzi, Lorenzo ^a,b,c,d,e   Bravo San Pedro, José Manuel ^a,b,c,d,e   Kepp, Oliver ^a,b,c,d,e   Kroemer, Guido ^{a,b,c,d,e,f,g}  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Autophagy; Ferroptosis; Mitochondrial permeability transition; Necroptosis

Indexed keywords

CELL DEATH; HOMEOSTASIS; STRESS; APOPTOSIS; AUTOPHAGY; EUKARYOTIC CELL; MITOCHONDRION; NECROSIS; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; AUTOPHAGY; EUKARYOTIC CELLS; HOMEOSTASIS; MITOCHONDRIA; NECROSIS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84962652590     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2209-y     Document Type: Review

References (52)

1. Lombard J, Lopez-Garcia P, Moreira D (2012) The early evolution of lipid membranes and the three domains of life. Nat Rev Microbiol 10:507–515. doi:10.1038/nrmicro2815
2. Orgel LE (1998) The origin of life—a review of facts and speculations. Trends Biochem Sci 23:491–495
3. Pearl LH, Schierz AC, Ward SE, Al-Lazikani B, Pearl FM (2015) Therapeutic opportunities within the DNA damage response. Nat Rev Cancer 15:166–180. doi:10.1038/nrc3891
4. Kroemer G, Marino G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40:280–293. doi:10.1016/j.molcel.2010.09.023
5. Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13:89–102. doi:10.1038/nrm3270
6. Hetz C, Chevet E, Harding HP (2013) Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12:703–719. doi:10.1038/nrd3976
7. Carmona-Gutierrez D, Eisenberg T, Buttner S, Meisinger C, Kroemer G, Madeo F (2010) Apoptosis in yeast: triggers, pathways, subroutines. Cell Death Differ 17:763–773. doi:10.1038/cdd.2009.219
8. Buttner S, Eisenberg T, Herker E, Carmona-Gutierrez D, Kroemer G, Madeo F (2006) Why yeast cells can undergo apoptosis: death in times of peace, love, and war. J Cell Biol 175:521–525. doi:10.1083/jcb.200608098
9. Madeo F, Herker E, Wissing S, Jungwirth H, Eisenberg T, Frohlich KU (2004) Apoptosis in yeast. Curr Opin Microbiol 7:655–660. doi:10.1016/j.mib.2004.10.012
10. Lam E (2004) Controlled cell death, plant survival and development. Nat Rev Mol Cell Biol 5:305–315. doi:10.1038/nrm1358
11. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E et al (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19:107–120. doi:10.1038/cdd.2011.96
12. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M et al (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16:3–11. doi:10.1038/cdd.2008.150
13. Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72. doi:10.1146/annurev-immunol-032712-100008
14. Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L et al (2014) Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 3:e955691. doi:10.4161/21624011.2014.955691
15. Fuchs Y, Steller H (2011) Programmed cell death in animal development and disease. Cell 147:742–758. doi:10.1016/j.cell.2011.10.033
16. Galluzzi L, Pietrocola F, Levine B, Kroemer G (2014) Metabolic control of autophagy. Cell 159:1263–1276. doi:10.1016/j.cell.2014.11.006
17. Green DR, Galluzzi L, Kroemer G (2014) Cell biology. Metabolic control of cell death. Science 345:1250256. doi:10.1126/science.1250256
18. Galluzzi L, Bravo-San Pedro JM, Kroemer G (2014) Organelle-specific initiation of cell death. Nat Cell Biol 16:728–736. doi:10.1038/ncb3005
19. Sica V, Galluzzi L, Bravo-San Pedro JM, Izzo V, Maiuri MC, Kroemer G (2015) Organelle-specific initiation of autophagy. Mol Cell 59:522–539. doi:10.1016/j.molcel.2015.07.021
20. Hardie DG, Ross FA, Hawley SA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13:251–262. doi:10.1038/nrm3311
21. Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G (2013) Metabolic targets for cancer therapy. Nat Rev Drug Discov 12:829–846. doi:10.1038/nrd4145
22. Avraham R, Yarden Y (2011) Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 12:104–117. doi:10.1038/nrm3048
23. Concha-Benavente F, Srivastava RM, Ferrone S, Ferris RL (2013) EGFR-mediated tumor immunoescape: the imbalance between phosphorylated STAT1 and phosphorylated STAT3. Oncoimmunology 2:e27215. doi:10.4161/onci.27215
24. Shiloh Y, Ziv Y (2013) The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14:197–210
25. Kruiswijk F, Labuschagne CF, Vousden KH (2015) p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16:393–405. doi:10.1038/nrm4007
26. Zirngibl K, Moll UM (2013) p53 further extends its reach. Oncoimmunology 2:e24959. doi:10.4161/onci.24959
27. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A et al (2015) Autophagy in malignant transformation and cancer progression. EMBO J 34:856–880. doi:10.15252/embj.201490784
28. Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G (2010) Autophagy regulation by p53. Curr Opin Cell Biol 22:181–185. doi:10.1016/j.ceb.2009.12.001
29. Bieging KT, Attardi LD (2012) Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol 22:97–106. doi:10.1016/j.tcb.2011.10.006
30. Bishehsari F, Gach JS, Akagi N, Webber MK, Bauer J, Jung BH (2014) Anti-p21 autoantibodies detected in colorectal cancer patients: a proof of concept study. Oncoimmunology 3:e952202. doi:10.4161/21624011.2014.952202
31. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397:271–274. doi:10.1038/16729
32. Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buque A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L (2015) eIF2alpha phosphorylation as a biomarker of immunogenic cell death. Semin Cancer Biol 33:86–92. doi:10.1016/j.semcancer.2015.02.004
33. Siekierka J, Manne V, Ochoa S (1984) Mechanism of translational control by partial phosphorylation of the alpha subunit of eukaryotic initiation factor 2. Proc Natl Acad Sci USA 81:352–356
34. Sarnow P (1989) Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited. Proc Natl Acad Sci USA 86:5795–5799
35. Vattem KM, Wek RC (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci USA 101:11269–11274. doi:10.1073/pnas.0400541101
36. Novoa I, Zeng H, Harding HP, Ron D (2001) Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 153:1011–1022
37. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D, Yuan J (2005) A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307:935–939. doi:10.1126/science.1101902
38. Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M, Kilberg MS et al (2013) ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol 15:481–490. doi:10.1038/ncb2738
39. Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH et al (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 22:58–73. doi:10.1038/cdd.2014.137
40. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. doi:10.1016/j.cell.2011.02.013
41. Le Bert N, Lam AR, Ho SS, Shen YJ, Liu MM, Gasser S (2014) STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression. Oncoimmunology 3:e29259. doi:10.4161/onci.29259
42. Galluzzi L, Kepp O, Kroemer G (2012) Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 13:780–788. doi:10.1038/nrm3479
43. Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L (2014) Trial watch: immunostimulatory cytokines in cancer therapy. Oncoimmunology 3:e29030. doi:10.4161/onci.29030
44. McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87–103. doi:10.1038/nri3787
45. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481–485. doi:10.1038/nature09907
46. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G (2008) Viral control of mitochondrial apoptosis. PLoS Pathog 4:e1000018. doi:10.1371/journal.ppat.1000018
47. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12:860–875. doi:10.1038/nrc3380
48. Kanegasaki S, Tsuchiya T (2014) Alarmins released during local antitumor treatments play an essential role in enhancing tumor growth inhibition at treated and non-treated sites via a derivative of CCL3. Oncoimmunology 3:e958956. doi:10.4161/21624011.2014.958956
49. Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209–223. doi:10.1016/j.immuni.2013.02.003
50. Spel L, Boelens JJ, Nierkens S, Boes M (2013) Antitumor immune responses mediated by dendritic cells: how signals derived from dying cancer cells drive antigen cross-presentation. Oncoimmunology 2:e26403. doi:10.4161/onci.26403
51. Workenhe ST, Mossman KL (2013) Rewiring cancer cell death to enhance oncolytic viro-immunotherapy. Oncoimmunology 2:e27138. doi:10.4161/onci.27138
52. Jiang H, Fueyo J (2014) Healing after death: antitumor immunity induced by oncolytic adenoviral therapy. Oncoimmunology 3:e947872. doi:10.4161/21624011.2014.947872